問卷
Log In
繁中 EN
TPIDB
TPIDB Outstanding PI
TPIDB > Principal Investigator

Principal Investigator


Linkou Chang Gung Medical Foundation (在職)

Division of Infectious Disease

更新時間：2024-06-04

陳南伃Chen, Nan-Yu
  • Co-Principal Investigator
  • Clinical Trial Experience (year) 9 years 2 個月

  • nanyuchen@cgmh.org.tw

Recruiting Trial

2Cases

篩選

Developmental Phase

  • Phase I

  • Phase I/II

  • Phase II

  • Phase II/III

  • Phase III

  • Phase IV

  • Others

Trial Status

  • Not yet recruiting

  • Active

  • Completed

Recruitment Status

  • Not yet recruiting

  • Recruiting

  • Completed

  • Terminated

  • Stop recruiting

  • Suspended

  • Study ended

Trial scale

  • Multi-Regional Multi-Center

  • Taiwan Multiple Center

  • Taiwan Single Center

The expected start time interval of the test

-

Trial Applicant

  • Hospital/Foundation

  • Pharmaceutical/Biopharmaceutical company

  • Contract Research Organization

Important Roles

  • Asia Regional PI

  • Taiwan National PI

  • Chairman/Global PI

  • Steering Committee

  • Advisory board

  • None

Audit by Sponsors/CRO

  • Sponsors

  • CRO

  • None

Investigator-initiated trial(IIT)

  • Yes

Filters

陳南伃

List

3Cases

2021-02-01 - 2026-12-31

Phase III

Active
A phase III, randomized, evaluator-blind, two-stage, two-way cross-over, active- and placebo-controlled, simulation study to evaluate the effectiveness and safety of Easy Antiseptic Cloth with 2% chlorhexidine gluconate (Aqua) as the topical antiseptics in healthy volunteers

  • Condition/Disease

    Disinfect before surgery

  • Test Drug

    Easy Antiseptic Cloth with 2% CHG(Aqua)

Participate Sites
5Sites

Recruiting5Sites

2022-12-09 - 2029-06-30

Phase III

Active
Randomized, Double-blind, Placebo-controlled, Multicenter Phase 3 Study to Assess the Efficacy, Safety And Immunogenicity of Vaccination With ExPEC9V in the Prevention of Invasive Extraintestinal Pathogenic Escherichia Coli Disease in Adults Aged 60 Years And Older With a History of Urinary Tract Infection in the Past 2 Years

  • Condition/Disease

    Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) Prevention

  • Test Drug

    ExPEC9V

Participate Sites
4Sites

Not yet recruiting3Sites

Recruiting1Sites

2025-04-01 - 2027-11-30

Phase III

Not yet recruiting
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of VE303 for Prevention of Recurrent Clostridioides Difficile Infection

  • Condition/Disease

    Prevention of recurrent Clostridioides difficile infection (CDI)

  • Test Drug

    VE303

Participate Sites
3Sites

Recruiting3Sites

聯絡我們

台灣臨床試驗主持人資料庫 TPIDB

All Contents Copyright 2020 台灣臨床試驗主持人資料庫TPIDB